Published on 29 Jul 2022 on Market Watch
AbbVie Inc. stock outperforms competitors despite losses on the day
Shares of AbbVie Inc. slipped 0.93% to $149.75 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.21% to 4,072.43 and the Dow Jones Industrial Average rising 1.03% to 32,529.63. The stock's fall snapped a five-day winning streak. AbbVie Inc. closed $26.16 below its 52-week high ($175.91), which the company reached on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Pfizer Inc. fell 1.61% to $50.72, Eli Lilly & Co. rose 0.57% to $330.80, and AstraZeneca PLC ADR fell 1.14% to $66.72. Trading volume (6.3 M) eclipsed its 50-day average volume of 6.0 M.